53950-14-4|Cefalexin lysine|Cephalexin (Cefalexin) lysine|-范德生物科技公司

Cefalexin lysine

NMR下载 COA and HPLC MSDS下载
names：
Cephalexin (Cefalexin) lysine
CAS号：
53950-14-4
MDL Number：
MF(分子式)： C22H31N5O6S MW(分子量)： 493.57
EINECS: Reaxys Number:
Pubchem ID: Brand:BIOFOUNT

Cephalexin (lysine) (别名：Cefalexin (lysine); Cephacillin (lysine))是含有赖氨酸的 Cephalexin 衍生物。Cephalexin 是一种强有力的口服活性的第一代头孢菌素抗生素 (cephalosporin antibiotic)。Cephalexin 通过破坏细菌细胞壁的生长来杀死革兰氏阳性和一些革兰氏阴性细菌。Cephalexin 用于肺炎、链球菌性咽喉炎、细菌性心内膜炎等的研究。

货品编码	规格	纯度	价格 (¥)	现价(¥)	特价(¥)	库存描述	数量	总计 (¥)
FMK13185-100mg	100mg	>98%	¥ 0.00	¥ 0.00		Get quote	- +	¥ 0.00

大包装询价提供各种包装，敬请垂询
收藏商品商品点评加入购物车立即购买

快速询价

收起

你想询价的产品

*产品名称：

CAS号：

产品编号：

需求描述：

请准确填写您的联系方式，以便为您提供最好的服务。

*公司名称：

*电子邮箱：

联系人：

*电话：

*验证码：

询价

中文别名	Cefalexin lysine
英文别名	Cefalexin lysine;
CAS号	53950-14-4
Inchi	InChI=1S/C16H17N3O4S.C6H14N2O2/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9;7-4-2-1-3-5(8)6(9)10/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23);5H,1-4,7-8H2,(H,9,10)/t10?,11-,15-;5-/m10/s1
InchiKey	CSXICSKZWGBACI-ZMZYGIGZSA-N
分子式 Formula	C22H31N5O6S
分子量 Molecular Weight	493.57
溶解度Solubility
性状	Solid powder
储藏条件 Storage conditions	Dry, dark and store at 0-4℃ for short term (days to weeks) or -20℃ for long term (Store correctly 2-3years).

产品说明	Cefalexin lysine(CAS:53950-14-4):仅限应用于工业或者科学研究过程中非医疗目的，不应用于人类或动物的临床诊断以及治过程疗，该产品非药用，非食用。
Introduction	Cefalexin lysine is a derivative of Cefalexin, an antibiotic.
Application1
Application2
Application3

警示图
危险性	Warning
危险性警示
安全声明
安全防护
备注

[1]Cadórniga R, Barrios S, Segura J, Roberts DJ. Penetration of antibiotic into interstitial tissue fluid following parenteral administration of lysine cephalexin. Arzneimittelforschung. 1979;29(10):1547-9. PubMed PMID: 583220.

[2]Barrios S, Sorensen JH, Spickett RG. Bioavailability of cephalexin after intramuscular injection of its lysine salt. J Pharm Pharmacol. 1975 Sep;27(9):711-2. PubMed PMID: 241820.

[3] Kale SN, Jadhav AD, Verma S, Koppikar SJ, Kaul-Ghanekar R, Dhole SD, Ogale SB. Characterization of biocompatible NiCo2O4 nanoparticles for applications in hyperthermia and drug delivery. Nanomedicine. 2012 May;8(4):452-9. doi: 10.1016/j.nano.2011.07.010. Epub 2011 Aug 10. PubMed PMID: 21839056.

[4] Nathan A, Zalipsky S, Ertel SI, Agathos SN, Yarmush ML, Kohn J. Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers. Bioconjug Chem. 1993 Jan-Feb;4(1):54-62. Erratum in: Bioconjug Chem 1993 Sep-Oct;4(5):410. PubMed PMID: 8431513.

[5] Fabregas JL, Beneyto JE. Direct spectrofluorimetric determination of the free amino group of cephalexin in its lysine salt. Analyst. 1980 Aug;105(1253):813-6. PubMed PMID: 6774629.

6: Fabregas JL, Beneyto JE. Simultaneous determination of cephalexin and lysine in their salt using high-performance liquid chromatography of derivatives. J Pharm Sci. 1980 Dec;69(12):1378-80. PubMed PMID: 6780683.7: Wang S, Arellano-Santoyo H, Combs PA, Shaevitz JW. Measuring the bending stiffness of bacterial cells using an optical trap. J Vis Exp. 2010 Apr 26;(38). pii: 2012. doi: 10.3791/2012. PubMed PMID: 20421864; PubMed Central PMCID: PMC3164081.8: Bundgaard H. Chemical studies related to cephalosporin allergy. II. Competitive amine-catalyzed intra- and intermolecular aminolysis of cephalexin and cephaloglycin in aqueous solution. Acta Pharm Suec. 1976;13(4):299-312. PubMed PMID: 11639.9: Albarellos GA, Montoya L, Quaine PC, Landoni MF. Pharmacokinetics and bioavailability of a long-acting formulation of cephalexin after intramuscular administration to cats. Res Vet Sci. 2011 Aug;91(1):129-31. doi: 10.1016/j.rvsc.2010.08.001. Epub 2010 Aug 25. PubMed PMID: 20800248.10: Addison JM, Burston D, Dalrymple JA, Matthews DM, Payne JW, Sleisenger MH, Wilkinson S. A common mechanism for transport of di- and tri-peptides by hamster jejunum in vitro. Clin Sci Mol Med. 1975 Oct;49(4):313-22. PubMed PMID: 1192691.1

对不起，暂无产品评价！

MSDS

SDS 1.0 中文

展开

SDS 1.0 英文

展开